JP2024524658A - 4-((r)-2-{[6-((s)-3-メトキシ-ピロリジン-1-イル)-2-フェニル-ピリミジン-4-カルボニル]-アミノ}-3-ホスホノ-プロピオニル)-ピペラジン-1-カルボン酸ブチルエステルの合成方法 - Google Patents

4-((r)-2-{[6-((s)-3-メトキシ-ピロリジン-1-イル)-2-フェニル-ピリミジン-4-カルボニル]-アミノ}-3-ホスホノ-プロピオニル)-ピペラジン-1-カルボン酸ブチルエステルの合成方法 Download PDF

Info

Publication number
JP2024524658A
JP2024524658A JP2024501708A JP2024501708A JP2024524658A JP 2024524658 A JP2024524658 A JP 2024524658A JP 2024501708 A JP2024501708 A JP 2024501708A JP 2024501708 A JP2024501708 A JP 2024501708A JP 2024524658 A JP2024524658 A JP 2024524658A
Authority
JP
Japan
Prior art keywords
compound
hcl
amount
mixture
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024501708A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524658A5 (https=
Inventor
ブルメール ニコル
クラヴォー ロマン
フェイアン ファビアン
ホール リアン
ヒューズ スティーブン
リーバー ステファン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idorsia Pharmaceuticals Ltd
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of JP2024524658A publication Critical patent/JP2024524658A/ja
Publication of JP2024524658A5 publication Critical patent/JP2024524658A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024501708A 2021-07-13 2022-07-11 4-((r)-2-{[6-((s)-3-メトキシ-ピロリジン-1-イル)-2-フェニル-ピリミジン-4-カルボニル]-アミノ}-3-ホスホノ-プロピオニル)-ピペラジン-1-カルボン酸ブチルエステルの合成方法 Pending JP2024524658A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2021/069486 2021-07-13
EP2021069486 2021-07-13
PCT/EP2022/069238 WO2023285342A2 (en) 2021-07-13 2022-07-11 A process for the synthesis of 4-((r)-2-{[6-((s)-3-methoxy-pyrrolidin-1-yl)-2-phenyl- pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1 -carboxylic acid butyl ester

Publications (2)

Publication Number Publication Date
JP2024524658A true JP2024524658A (ja) 2024-07-05
JP2024524658A5 JP2024524658A5 (https=) 2025-07-02

Family

ID=82748669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024501708A Pending JP2024524658A (ja) 2021-07-13 2022-07-11 4-((r)-2-{[6-((s)-3-メトキシ-ピロリジン-1-イル)-2-フェニル-ピリミジン-4-カルボニル]-アミノ}-3-ホスホノ-プロピオニル)-ピペラジン-1-カルボン酸ブチルエステルの合成方法

Country Status (10)

Country Link
US (1) US20240317784A1 (https=)
EP (1) EP4370525A2 (https=)
JP (1) JP2024524658A (https=)
KR (1) KR20240033005A (https=)
CN (1) CN117616033A (https=)
CA (1) CA3223733A1 (https=)
IL (1) IL309948A (https=)
MX (1) MX2024000653A (https=)
TW (1) TW202317140A (https=)
WO (1) WO2023285342A2 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011505352A (ja) * 2007-11-29 2011-02-24 アクテリオン ファーマシューティカルズ リミテッド ホスホン酸誘導体及びp2y12受容体拮抗剤としてのそれらの使用
JP2019529553A (ja) * 2016-09-22 2019-10-17 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd 結晶形

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA49887A (fr) 2017-03-15 2020-06-24 Idorsia Pharmaceuticals Ltd Administration sous-cutanée d'un antagoniste du récepteur p2y12

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011505352A (ja) * 2007-11-29 2011-02-24 アクテリオン ファーマシューティカルズ リミテッド ホスホン酸誘導体及びp2y12受容体拮抗剤としてのそれらの使用
JP2019529553A (ja) * 2016-09-22 2019-10-17 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd 結晶形

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
平山令明, 有機化合物結晶作製ハンドブック, JPN6014035600, 2008, pages 17 - 23, ISSN: 0005834964 *
浅原 照三ほか編, 溶剤ハンドブック, JPN6011026738, 1985, ISSN: 0005834965 *

Also Published As

Publication number Publication date
KR20240033005A (ko) 2024-03-12
IL309948A (en) 2024-03-01
WO2023285342A3 (en) 2023-04-13
WO2023285342A2 (en) 2023-01-19
TW202317140A (zh) 2023-05-01
CN117616033A (zh) 2024-02-27
CA3223733A1 (en) 2023-01-19
EP4370525A2 (en) 2024-05-22
US20240317784A1 (en) 2024-09-26
MX2024000653A (es) 2024-01-31

Similar Documents

Publication Publication Date Title
KR101404893B1 (ko) 트랜스-4-[[(5s)-5-[[[3,5-비스(트리플루오로메틸)페닐]메틸] (2-메틸-2h-테트라졸-5-일)아미노]-2,3,4,5-테트라히드로-7,9-디메틸-1h-1-벤즈아제핀-1-일]메틸]-시클로헥산카르복실산
WO2019053607A1 (en) PROCESS FOR PREPARING LIFITEGRAST
CN107922352B (zh) 制备蛋白质脱乙酰酶抑制剂的方法
WO2017221189A1 (en) An improved process for the preparation of tenofovir alafenamide or pharmaceutically acceptable salts thereof
JP2023062072A (ja) Rorガンマの阻害剤
CZ2014502A3 (cs) Nová forma sofosbuviru a způsob její přípravy
JP2611816B2 (ja) N−(ヒドロキシ)アラルキルフェニルエタノールアミン類のo−アルキル化方法
CN105164096A (zh) 手性犬尿氨酸化合物和中间体的合成
CN105517992B (zh) 新型结晶性芳烷基胺化合物及其制造方法
JP2024524658A (ja) 4-((r)-2-{[6-((s)-3-メトキシ-ピロリジン-1-イル)-2-フェニル-ピリミジン-4-カルボニル]-アミノ}-3-ホスホノ-プロピオニル)-ピペラジン-1-カルボン酸ブチルエステルの合成方法
US20240262805A1 (en) Method for producing compound or pharmaceutically acceptable salt thereof
CN116113636A (zh) 4-硼-l-苯基丙氨酸及其中间体的制造方法
TWI826724B (zh) 用以製造1,5-苯并噻氮呯化合物之方法
EP3658569B1 (en) Process and intermediates for synthesis of peptide compounds
CN1028361C (zh) 戊二酸衍生物的制备方法
JP4829418B2 (ja) 光学活性なハロヒドリン誘導体およびその使用方法
TWI872173B (zh) ((2s)-3-([1,1'-聯苯]-4-基)-2-((羥基((1r)-1-(((1-(異丁醯氧基)乙氧基)羰基)胺基)乙基)磷醯基)甲基)丙醯基)-l-丙胺酸的二鈉鹽的工業製備方法
CN101492431A (zh) 马来酸桂哌齐特的制备方法
HK40111936A (en) Method for producing compound or pharmaceutically acceptable salt thereof
KR20040105791A (ko) 트리테르펜 유도체의 제조 방법
EP1498410A1 (en) Process for producing tert-leucine
CN117945945A (zh) 一种gpr139受体激动剂、其制备方法及其应用
HK40088032A (zh) 4-硼-l-苯基丙氨酸及其中间体的制造方法
US20050107473A1 (en) Process for producing tert-leucine
JPH0541639B2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250619

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250619

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20250619

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260319

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260407